RecruitingPhase 2NCT04913805

Matching Perfusion and Metabolic Activity in HFpEF


Sponsor

University of Pennsylvania

Enrollment

53 participants

Start Date

Oct 11, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This study will test whether pharmacologic agents that increase perfusion \[Potassium Nitrate (KNO3)\], with and without additional supplements that may improve mitochondrial function \[Propionyl-L-Carnitine (PLC) and Nicotinamide Riboside (NR)\], improve submaximal exercise endurance and skeletal muscle oxidative phosphorylation capacity (SkM OxPhos) in participants with Heart Failure with Preserved Ejection Fraction (HFpEF).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating a type of heart failure called HFpEF (heart failure with preserved ejection fraction), where the heart pumps normally but is too stiff. Researchers are looking at how blood flow and energy use in the heart muscle are matched or mismatched. **You may be eligible if:** - You have moderate heart failure symptoms (breathlessness or fatigue with activity) - Your heart's pumping function is at least 50% (relatively normal) - Your condition has been stable for at least 2 weeks - You have evidence of increased pressure inside your heart (based on echocardiogram or prior testing) - You are 18 or older **You may NOT be eligible if:** - You are pregnant - You take certain heart medications (nitrates or phosphodiesterase inhibitors) that cannot be stopped - Your heart rate is uncontrolled (resting rate above 100 beats per minute due to atrial fibrillation) - You have severe anemia, significant heart valve disease, hypertrophic cardiomyopathy, or serious lung disease - Your kidney function is severely impaired (eGFR below 30) - You are unable or unwilling to exercise Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPotassium Nitrate

Potassium Nitrate is the active intervention that may increase blood flow to exercising muscle

DRUGPotassium Nitrate + Propionyl-L-Carnitine + Nicotinamide Riboside

Potassium Nitrate + Propionyl-L-Carnitine + Nicotinamide Riboside will be used as a combination intervention to both increase blood flow (KNO3) and mitochondrial function (PLC + NR)

OTHERPotassium Chloride

Active control


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04913805


Related Trials